Found 137 hits with Last Name = 'chalmers' and Initial = 'dk' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50315213
(2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-t...)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1 Show InChI InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| MMDB
PDB
Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50315213
(2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-t...)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1 Show InChI InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50315213
(2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-t...)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1 Show InChI InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426459
(CHEMBL2322668)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCN(CC1)C(=O)[C@@H]1CCCN1)N1CCOCC1 |r| Show InChI InChI=1S/C24H29F2N9O2/c25-19(26)20-28-16-4-1-2-6-18(16)35(20)24-30-22(29-23(31-24)34-12-14-37-15-13-34)33-10-8-32(9-11-33)21(36)17-5-3-7-27-17/h1-2,4,6,17,19,27H,3,5,7-15H2/t17-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426453
(CHEMBL2322661)Show SMILES CC(=O)NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H27F2N9O3/c1-15(35)26-14-18(36)31-6-8-32(9-7-31)21-28-22(33-10-12-37-13-11-33)30-23(29-21)34-17-5-3-2-4-16(17)27-20(34)19(24)25/h2-5,19H,6-14H2,1H3,(H,26,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426452
(CHEMBL2322662)Show SMILES C[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426454
(CHEMBL2322660)Show SMILES NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C21H25F2N9O2/c22-17(23)18-25-14-3-1-2-4-15(14)32(18)21-27-19(26-20(28-21)31-9-11-34-12-10-31)30-7-5-29(6-8-30)16(33)13-24/h1-4,17H,5-13,24H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50315213
(2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-t...)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1 Show InChI InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426453
(CHEMBL2322661)Show SMILES CC(=O)NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H27F2N9O3/c1-15(35)26-14-18(36)31-6-8-32(9-7-31)21-28-22(33-10-12-37-13-11-33)30-23(29-21)34-17-5-3-2-4-16(17)27-20(34)19(24)25/h2-5,19H,6-14H2,1H3,(H,26,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426458
(CHEMBL2322669)Show SMILES NCCCC[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H34F2N10O2/c26-20(27)21-30-18-6-1-2-7-19(18)37(21)25-32-23(31-24(33-25)36-13-15-39-16-14-36)35-11-9-34(10-12-35)22(38)17(29)5-3-4-8-28/h1-2,6-7,17,20H,3-5,8-16,28-29H2/t17-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426453
(CHEMBL2322661)Show SMILES CC(=O)NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H27F2N9O3/c1-15(35)26-14-18(36)31-6-8-32(9-7-31)21-28-22(33-10-12-37-13-11-33)30-23(29-21)34-17-5-3-2-4-16(17)27-20(34)19(24)25/h2-5,19H,6-14H2,1H3,(H,26,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426457
(CHEMBL2322670)Show SMILES NCCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C22H27F2N9O2/c23-18(24)19-26-15-3-1-2-4-16(15)33(19)22-28-20(27-21(29-22)32-11-13-35-14-12-32)31-9-7-30(8-10-31)17(34)5-6-25/h1-4,18H,5-14,25H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426452
(CHEMBL2322662)Show SMILES C[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 100 uM ATP as ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426450
(CHEMBL2322664)Show SMILES N[C@@H](Cc1ccccc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O2/c29-23(30)24-32-21-8-4-5-9-22(21)39(24)28-34-26(33-27(35-28)38-14-16-41-17-15-38)37-12-10-36(11-13-37)25(40)20(31)18-19-6-2-1-3-7-19/h1-9,20,23H,10-18,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426448
(CHEMBL2322666)Show SMILES CC[C@H](C)[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H33F2N9O2/c1-3-16(2)19(28)22(37)33-8-10-34(11-9-33)23-30-24(35-12-14-38-15-13-35)32-25(31-23)36-18-7-5-4-6-17(18)29-21(36)20(26)27/h4-7,16,19-20H,3,8-15,28H2,1-2H3/t16-,19-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426451
(CHEMBL2322663)Show SMILES C[C@@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426450
(CHEMBL2322664)Show SMILES N[C@@H](Cc1ccccc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O2/c29-23(30)24-32-21-8-4-5-9-22(21)39(24)28-34-26(33-27(35-28)38-14-16-41-17-15-38)37-12-10-36(11-13-37)25(40)20(31)18-19-6-2-1-3-7-19/h1-9,20,23H,10-18,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 100 uM ATP as ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426457
(CHEMBL2322670)Show SMILES NCCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C22H27F2N9O2/c23-18(24)19-26-15-3-1-2-4-16(15)33(19)22-28-20(27-21(29-22)32-11-13-35-14-12-32)31-9-7-30(8-10-31)17(34)5-6-25/h1-4,18H,5-14,25H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 98 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426454
(CHEMBL2322660)Show SMILES NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C21H25F2N9O2/c22-17(23)18-25-14-3-1-2-4-15(14)32(18)21-27-19(26-20(28-21)31-9-11-34-12-10-31)30-7-5-29(6-8-30)16(33)13-24/h1-4,17H,5-13,24H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426448
(CHEMBL2322666)Show SMILES CC[C@H](C)[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H33F2N9O2/c1-3-16(2)19(28)22(37)33-8-10-34(11-9-33)23-30-24(35-12-14-38-15-13-35)32-25(31-23)36-18-7-5-4-6-17(18)29-21(36)20(26)27/h4-7,16,19-20H,3,8-15,28H2,1-2H3/t16-,19-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 100 uM ATP as ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426460
(CHEMBL2322667)Show SMILES N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O3/c29-23(30)24-32-21-3-1-2-4-22(21)39(24)28-34-26(33-27(35-28)38-13-15-42-16-14-38)37-11-9-36(10-12-37)25(41)20(31)17-18-5-7-19(40)8-6-18/h1-8,20,23,40H,9-17,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426456
(CHEMBL2322671)Show SMILES CN[C@@H](C)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C23H29F2N9O2/c1-15(26-2)20(35)31-7-9-32(10-8-31)21-28-22(33-11-13-36-14-12-33)30-23(29-21)34-17-6-4-3-5-16(17)27-19(34)18(24)25/h3-6,15,18,26H,7-14H2,1-2H3/t15-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426456
(CHEMBL2322671)Show SMILES CN[C@@H](C)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C23H29F2N9O2/c1-15(26-2)20(35)31-7-9-32(10-8-31)21-28-22(33-11-13-36-14-12-33)30-23(29-21)34-17-6-4-3-5-16(17)27-19(34)18(24)25/h3-6,15,18,26H,7-14H2,1-2H3/t15-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426455
(CHEMBL2322672)Show SMILES CN(C)CC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H29F2N9O2/c1-30(2)15-18(35)31-7-9-32(10-8-31)21-27-22(33-11-13-36-14-12-33)29-23(28-21)34-17-6-4-3-5-16(17)26-20(34)19(24)25/h3-6,19H,7-15H2,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50426453
(CHEMBL2322661)Show SMILES CC(=O)NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H27F2N9O3/c1-15(35)26-14-18(36)31-6-8-32(9-7-31)21-28-22(33-10-12-37-13-11-33)30-23(29-21)34-17-5-3-2-4-16(17)27-20(34)19(24)25/h2-5,19H,6-14H2,1H3,(H,26,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426459
(CHEMBL2322668)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCN(CC1)C(=O)[C@@H]1CCCN1)N1CCOCC1 |r| Show InChI InChI=1S/C24H29F2N9O2/c25-19(26)20-28-16-4-1-2-6-18(16)35(20)24-30-22(29-23(31-24)34-12-14-37-15-13-34)33-10-8-32(9-11-33)21(36)17-5-3-7-27-17/h1-2,4,6,17,19,27H,3,5,7-15H2/t17-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 390 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426452
(CHEMBL2322662)Show SMILES C[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426458
(CHEMBL2322669)Show SMILES NCCCC[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H34F2N10O2/c26-20(27)21-30-18-6-1-2-7-19(18)37(21)25-32-23(31-24(33-25)36-13-15-39-16-14-36)35-11-9-34(10-12-35)22(38)17(29)5-3-4-8-28/h1-2,6-7,17,20H,3-5,8-16,28-29H2/t17-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 670 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426457
(CHEMBL2322670)Show SMILES NCCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C22H27F2N9O2/c23-18(24)19-26-15-3-1-2-4-16(15)33(19)22-28-20(27-21(29-22)32-11-13-35-14-12-32)31-9-7-30(8-10-31)17(34)5-6-25/h1-4,18H,5-14,25H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 720 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426448
(CHEMBL2322666)Show SMILES CC[C@H](C)[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H33F2N9O2/c1-3-16(2)19(28)22(37)33-8-10-34(11-9-33)23-30-24(35-12-14-38-15-13-35)32-25(31-23)36-18-7-5-4-6-17(18)29-21(36)20(26)27/h4-7,16,19-20H,3,8-15,28H2,1-2H3/t16-,19-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426451
(CHEMBL2322663)Show SMILES C[C@@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426460
(CHEMBL2322667)Show SMILES N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O3/c29-23(30)24-32-21-3-1-2-4-22(21)39(24)28-34-26(33-27(35-28)38-13-15-42-16-14-38)37-11-9-36(10-12-37)25(41)20(31)17-18-5-7-19(40)8-6-18/h1-8,20,23,40H,9-17,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426456
(CHEMBL2322671)Show SMILES CN[C@@H](C)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C23H29F2N9O2/c1-15(26-2)20(35)31-7-9-32(10-8-31)21-28-22(33-11-13-36-14-12-33)30-23(29-21)34-17-6-4-3-5-16(17)27-19(34)18(24)25/h3-6,15,18,26H,7-14H2,1-2H3/t15-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426454
(CHEMBL2322660)Show SMILES NCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C21H25F2N9O2/c22-17(23)18-25-14-3-1-2-4-15(14)32(18)21-27-19(26-20(28-21)31-9-11-34-12-10-31)30-7-5-29(6-8-30)16(33)13-24/h1-4,17H,5-13,24H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426455
(CHEMBL2322672)Show SMILES CN(C)CC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H29F2N9O2/c1-30(2)15-18(35)31-7-9-32(10-8-31)21-27-22(33-11-13-36-14-12-33)29-23(28-21)34-17-6-4-3-5-16(17)26-20(34)19(24)25/h3-6,19H,7-15H2,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50426451
(CHEMBL2322663)Show SMILES C[C@@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426459
(CHEMBL2322668)Show SMILES FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCN(CC1)C(=O)[C@@H]1CCCN1)N1CCOCC1 |r| Show InChI InChI=1S/C24H29F2N9O2/c25-19(26)20-28-16-4-1-2-6-18(16)35(20)24-30-22(29-23(31-24)34-12-14-37-15-13-34)33-10-8-32(9-11-33)21(36)17-5-3-7-27-17/h1-2,4,6,17,19,27H,3,5,7-15H2/t17-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426450
(CHEMBL2322664)Show SMILES N[C@@H](Cc1ccccc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O2/c29-23(30)24-32-21-8-4-5-9-22(21)39(24)28-34-26(33-27(35-28)38-14-16-41-17-15-38)37-12-10-36(11-13-37)25(40)20(31)18-19-6-2-1-3-7-19/h1-9,20,23H,10-18,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426458
(CHEMBL2322669)Show SMILES NCCCC[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H34F2N10O2/c26-20(27)21-30-18-6-1-2-7-19(18)37(21)25-32-23(31-24(33-25)36-13-15-39-16-14-36)35-11-9-34(10-12-35)22(38)17(29)5-3-4-8-28/h1-2,6-7,17,20H,3-5,8-16,28-29H2/t17-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50426455
(CHEMBL2322672)Show SMILES CN(C)CC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C23H29F2N9O2/c1-30(2)15-18(35)31-7-9-32(10-8-31)21-27-22(33-11-13-36-14-12-33)29-23(28-21)34-17-6-4-3-5-16(17)26-20(34)19(24)25/h3-6,19H,7-15H2,1-2H3 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426460
(CHEMBL2322667)Show SMILES N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O3/c29-23(30)24-32-21-3-1-2-4-22(21)39(24)28-34-26(33-27(35-28)38-13-15-42-16-14-38)37-11-9-36(10-12-37)25(41)20(31)17-18-5-7-19(40)8-6-18/h1-8,20,23,40H,9-17,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426452
(CHEMBL2322662)Show SMILES C[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50426452
(CHEMBL2322662)Show SMILES C[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50426449
(CHEMBL2322665)Show SMILES N[C@H](Cc1ccccc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O2/c29-23(30)24-32-21-8-4-5-9-22(21)39(24)28-34-26(33-27(35-28)38-14-16-41-17-15-38)37-12-10-36(11-13-37)25(40)20(31)18-19-6-2-1-3-7-19/h1-9,20,23H,10-18,31H2/t20-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426451
(CHEMBL2322663)Show SMILES C[C@@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50426457
(CHEMBL2322670)Show SMILES NCCC(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 Show InChI InChI=1S/C22H27F2N9O2/c23-18(24)19-26-15-3-1-2-4-16(15)33(19)22-28-20(27-21(29-22)32-11-13-35-14-12-32)31-9-7-30(8-10-31)17(34)5-6-25/h1-4,18H,5-14,25H2 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426450
(CHEMBL2322664)Show SMILES N[C@@H](Cc1ccccc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C28H31F2N9O2/c29-23(30)24-32-21-8-4-5-9-22(21)39(24)28-34-26(33-27(35-28)38-14-16-41-17-15-38)37-12-10-36(11-13-37)25(40)20(31)18-19-6-2-1-3-7-19/h1-9,20,23H,10-18,31H2/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426448
(CHEMBL2322666)Show SMILES CC[C@H](C)[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C25H33F2N9O2/c1-3-16(2)19(28)22(37)33-8-10-34(11-9-33)23-30-24(35-12-14-38-15-13-35)32-25(31-23)36-18-7-5-4-6-17(18)29-21(36)20(26)27/h4-7,16,19-20H,3,8-15,28H2,1-2H3/t16-,19-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50426456
(CHEMBL2322671)Show SMILES CN[C@@H](C)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C23H29F2N9O2/c1-15(26-2)20(35)31-7-9-32(10-8-31)21-28-22(33-11-13-36-14-12-33)30-23(29-21)34-17-6-4-3-5-16(17)27-19(34)18(24)25/h3-6,15,18,26H,7-14H2,1-2H3/t15-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50426452
(CHEMBL2322662)Show SMILES C[C@H](N)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1 |r| Show InChI InChI=1S/C22H27F2N9O2/c1-14(25)19(34)30-6-8-31(9-7-30)20-27-21(32-10-12-35-13-11-32)29-22(28-20)33-16-5-3-2-4-15(16)26-18(33)17(23)24/h2-5,14,17H,6-13,25H2,1H3/t14-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Monash University (Parkville Campus)
Curated by ChEMBL
| Assay Description
Inhibition of wild type PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 100 uM ATP as... |
ACS Med Chem Lett 4: 206-210 (2013)
Article DOI: 10.1021/ml300336j
BindingDB Entry DOI: 10.7270/Q2JH3NHG |
More data for this
Ligand-Target Pair | |
Search and Browse
